Ann: Symbol Undertakes Oversubscribed Capital Raising of A$3.0m, page-28

First 28 Last

Share
Profile

Follow
bucks369

53 Posts.

24

17/05/18

10:19

Post #: 33155455
Share

Originally posted by cdchi1 ↑

The options are the reason I'm now a seller (pls read rest of post before saying im a downramper). I don't mind a capital raising, in fact am often in favour of them, but only when its done at a reasonable price (which was the case here) but more importantly, without these kind of freebie shenanigans.

I do not believe the company is a bad one, the project(s) look very good too me and I am sure they will pick up additional projects. But this CR has left a bad taste in my mouth (bc of the oppies) and therefore I am currently selling, at a decent loss. My cap gains situation has some influence too though.

Before anyone says "Ahh your just jealous", I could have taken up the placement myself and flogged the shares after and just kept the oppies, but that's not how I operate.

Heck if they had come to me directly and offered the CR at 3c Without options I would have been more than happy to take it up.

Having said all that, as I said before the company's projects are very good ones imo and if they can get going with production as planned, it is still very underpriced. The company remains on my watchlist and I may well decide to reinvest depending on progress.

Cdchi1

Expand

Cdchi1 I believe you have contact with some of the management that came over from Echo, have you spoken to them on this issue?

SL1 Price at posting: 3.0¢ Sentiment: Buy Disclosure: Held
Upvote

0 Great analysis

Reply

Top Stories

WC8

Pan Asia rebranding to 'clear confusion' after bagging $35M for Chile projects

MIN

MinRes's Ellison knows he screwed up – for that reason, hunt for new Chair to be sped up

History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025

EDE

Empire Energy locks in $65M funding deal with Macquarie to develop NT's Beetaloo Basin

ACW

This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game

There are more pages in this discussion • 48 more messages in this thread...

First 28 Last

Add SL1 (ASX) to my watchlist

Ann: Symbol Undertakes Oversubscribed Capital Raising of A$3.0m, page-28

Top Stories

Pan Asia rebranding to 'clear confusion' after bagging $35M for Chile projects

MinRes's Ellison knows he screwed up – for that reason, hunt for new Chair to be sped up

History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025

Empire Energy locks in $65M funding deal with Macquarie to develop NT's Beetaloo Basin

This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game